1. Home
  2. OCUL vs TMP Comparison

OCUL vs TMP Comparison

Compare OCUL & TMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • TMP
  • Stock Information
  • Founded
  • OCUL 2006
  • TMP 1836
  • Country
  • OCUL United States
  • TMP United States
  • Employees
  • OCUL N/A
  • TMP N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • TMP Major Banks
  • Sector
  • OCUL Health Care
  • TMP Finance
  • Exchange
  • OCUL Nasdaq
  • TMP Nasdaq
  • Market Cap
  • OCUL 957.3M
  • TMP 893.3M
  • IPO Year
  • OCUL 2014
  • TMP N/A
  • Fundamental
  • Price
  • OCUL $7.06
  • TMP $61.81
  • Analyst Decision
  • OCUL Strong Buy
  • TMP Buy
  • Analyst Count
  • OCUL 10
  • TMP 2
  • Target Price
  • OCUL $16.11
  • TMP $69.00
  • AVG Volume (30 Days)
  • OCUL 1.6M
  • TMP 45.0K
  • Earning Date
  • OCUL 05-05-2025
  • TMP 04-25-2025
  • Dividend Yield
  • OCUL N/A
  • TMP 4.04%
  • EPS Growth
  • OCUL N/A
  • TMP 653.03
  • EPS
  • OCUL N/A
  • TMP 5.16
  • Revenue
  • OCUL $59,647,000.00
  • TMP $297,067,000.00
  • Revenue This Year
  • OCUL $13.32
  • TMP $12.86
  • Revenue Next Year
  • OCUL $13.13
  • TMP $7.68
  • P/E Ratio
  • OCUL N/A
  • TMP $11.91
  • Revenue Growth
  • OCUL N/A
  • TMP 35.84
  • 52 Week Low
  • OCUL $4.06
  • TMP $43.32
  • 52 Week High
  • OCUL $11.78
  • TMP $79.01
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 44.18
  • TMP 55.86
  • Support Level
  • OCUL $6.84
  • TMP $60.24
  • Resistance Level
  • OCUL $8.90
  • TMP $62.82
  • Average True Range (ATR)
  • OCUL 0.47
  • TMP 1.71
  • MACD
  • OCUL -0.11
  • TMP 0.59
  • Stochastic Oscillator
  • OCUL 10.71
  • TMP 86.24

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About TMP Tompkins Financial Corporation

Tompkins Financial Corp is a Financial Holding Company. It has three business segments, consisting of banking, insurance and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Insurance is comprised of property and casualty insurance services and employee benefit consulting. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates majority of its revenue from Banking segment.

Share on Social Networks: